Posts

Showing posts from September, 2020

INFINITY PAY!

Image
  Tired of all the time and effort you’re putting into your network marketing business only to be paid a fraction of what you expected to earn? You need INFINITY 7 from CTFO! Launching on 1st June, INFINITY 7 has the power to pay you any figure you can come up with! This is possible because, as the word suggests, INFINITY 7 pays to infinity on your team business. NO cut-offs ever! No Balancing Legs! No Breakage to Company! 100 levels… 1,000 levels…. 10,000 levels deep, you get paid on it ALL! And INFINITY 7 pays up to 35% on your entire team! Remember this is ON TOP of all our other commissions and bonuses including a new LOYALTY BONUS paying up to $3,000 a month! It does not get any better than this!!! YOU SHOULD DEMAND A 60-day guaranty, lab-tested (COA), GMP seal, organic CBD, and CBD products where ever you  buy CBD.   We provide this to all our customers. Disclaimer:  The information made available on this page is based on studies and research as well as reported experiences fro

Survey: 84% of CBD Consumers Believe CBD Can Replace Opioids

Image
  By Graham Abbott,  Ganjapreneur's Chief Editor About 84% of CBD consumers believe the cannabinoid is an effective alternative to opioids, according to a recent study from  AmericanMarijuana.org . The study surveyed 1,453 consumers who reported using CBD as a pain relief treatment. While the majority of respondents were both regular CBD consumers and millennials, non-regular users represented about one-third of respondents, while Baby Boomers represented about 8% of respondents, Gen Z represented about 12%, and Gen X about 19%. A whopping 97% of respondents reported using fewer opioids after starting CBD — about 57% said they were using fewer opioids while some 40% said they had stopped their opioid use altogether. 53% of respondents said that CBD had become their only source of pain relief. “This study suggests that what we now need is controlled research to understand CBD’s pain-relieving effects (there is surprisingly very little research published in this area on humans). With